Efficacy of Sevikar Compared to the Combination of Perindopril/Amlodipine on Central Arterial Blood Pressure in Patients With Moderate to Severe Hypertension.

Trial Profile

Efficacy of Sevikar Compared to the Combination of Perindopril/Amlodipine on Central Arterial Blood Pressure in Patients With Moderate to Severe Hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2015

At a glance

  • Drugs Olmesartan medoxomil/amlodipine (Primary) ; Amlodipine; Hydrochlorothiazide; Perindopril
  • Indications Essential hypertension; Hypertension
  • Focus Therapeutic Use
  • Acronyms SEVITENSION
  • Sponsors Daiichi Sankyo Europe
  • Most Recent Events

    • 23 Sep 2015 Results of a post hoc subgroup (diabetic patients) analysis published in the Journal of Clinical Hypertension (Greenwich).
    • 25 Jun 2013 Primary endpoint 'Central-systolic-blood-pressure' has been met.
    • 25 Jun 2013 First findings from this study were revealed at an ESH 2013 poster session, according to a Daiichi Sankyo media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top